A Phase 2, Multi-Center, Open-Label Study to Evaluate Long-term Safety and Efficacy of CXA-10 in Subjects with Pulmonary Arterial Hypertension on Stable Background Therapy: Extension to Study CXA-10-301 (Complexa CXA-10-2302 - PRIMEx Open Label Extension
|Effective start/end date||2/1/20 → 2/28/23|
- COMPLEXA INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.